OBJECTIVE: This multisite, randomized, crossover trial comparing the performance of the Reality female condom (FC1) with a new synthetic latex prototype (FC2) was conducted in Durban, South Africa. METHOD: In total, 276 women were enrolled and 201 women completed the study. Altogether, 1910 FC1 condoms and 1,881 FC2 condoms were used. RESULTS:Total breakage was 0.73% in FC1 and 0.85% in FC2 (95% confidence interval, -0.64 to 0.87). The number of clinical breakages (those that could result in a pregnancy or sexually transmitted infection) was similar for each condom type (FC1, n=9; FC2, n=8). Incorrect penetration (penis between condom and vaginal wall) was 1.26% and 0.64% for FC1 and FC2, respectively. Outer ring displacements (outer ring pushed into the vagina partially or fully) were comparable for both condoms (FC1, 3.14%; FC2, 2.98%). Slippage (condom came out of the vagina) was rare and reported in 0.37% or less of devices used. Total clinical failure was 5.24% in FC1 and 4.3% in FC2. CONCLUSION: The FC1 and FC2 performed comparably within this trial.
RCT Entities:
OBJECTIVE: This multisite, randomized, crossover trial comparing the performance of the Reality female condom (FC1) with a new synthetic latex prototype (FC2) was conducted in Durban, South Africa. METHOD: In total, 276 women were enrolled and 201 women completed the study. Altogether, 1910 FC1 condoms and 1,881 FC2 condoms were used. RESULTS: Total breakage was 0.73% in FC1 and 0.85% in FC2 (95% confidence interval, -0.64 to 0.87). The number of clinical breakages (those that could result in a pregnancy or sexually transmitted infection) was similar for each condom type (FC1, n=9; FC2, n=8). Incorrect penetration (penis between condom and vaginal wall) was 1.26% and 0.64% for FC1 and FC2, respectively. Outer ring displacements (outer ring pushed into the vagina partially or fully) were comparable for both condoms (FC1, 3.14%; FC2, 2.98%). Slippage (condom came out of the vagina) was rare and reported in 0.37% or less of devices used. Total clinical failure was 5.24% in FC1 and 4.3% in FC2. CONCLUSION: The FC1 and FC2 performed comparably within this trial.
Authors: Donald A Calsyn; Mary A Hatch-Maillette; Suzanne R Doyle; Sarah Cousins; TeChieh Chen; Melinda Godinez Journal: Subst Abus Date: 2010-10 Impact factor: 3.716
Authors: R John Aitken; Mark A Baker; Gustavo F Doncel; Martin M Matzuk; Christine K Mauck; Michael J K Harper Journal: J Clin Invest Date: 2008-04 Impact factor: 14.808
Authors: Joanne E Mantell; Brooke S West; Kimberly Sue; Susie Hoffman; Theresa M Exner; Elizabeth Kelvin; Zena A Stein Journal: AIDS Educ Prev Date: 2011-02
Authors: Beatrice A Chen; Diana L Blithe; Gitonga R Muraguri; Audrey A Lance; Bruce R Carr; Jeffrey T Jensen; Thomas D Kimble; Amitasrigowri S Murthy; Courtney A Schreiber; Michael A Thomas; Terri L Walsh; Carolyn Westhoff; Anne E Burke Journal: Contraception Date: 2019-03-06 Impact factor: 3.375
Authors: Aaron J Siegler; Elizabeth M Rosenthal; Patrick S Sullivan; Lauren Ahlschlager; Colleen F Kelley; C Christina Mehta; Reneé H Moore; Eli S Rosenberg; Michael P Cecil Journal: JMIR Res Protoc Date: 2019-04-23